Tune in to see current topics that are affecting HTCs.

Understanding VWD introduces the symptoms and types of von Willebrand disease, and discusses potential approaches to treatment based on patient needs.

To provide all available key Jivi (antihemophilic factor (recombinant) PEGylated-aucl) data.

* Joe's Update - OPA Recertification
* DC Update - What to expect from Congress
* Payer Update

Join us for an interactive webinar focused on having discussions with your patients about trying treatments outside their comfort zone. We will be screening a new video from the “Tough Questions” series and hear from expert panelists as they discuss their real-world experiences on this topic.

• Joe's Update - OPA Recertification
• Michael Craciunoiu - Harmony in Hemophilia
• Payer Update for 2021

We will review the clinical features, diagnosis, and management of acquired hemophilia A (AHA), share the clinical study data supporting the indication of OBIZUR for treatment of bleeding episodes in adults with AHA, and discuss patient cases in which OBIZUR may be an appropriate treatment option.